EW•benzinga•
Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens
Summary
Edwards Lifesciences raised 2025 revenue forecast after Q1 results beat EPS estimates and TMTT sales jumped 58% amid strong global demand.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 24, 2025 by benzinga